Feb 23, 2021
MENTAL WELLNESS ART FUNDRAISER: Mental Health is Vital has partnered with The Ryan Giambattista HELMS Foundation of the Mahoning Valley for its annual art fundraiser.
This year’s event will be a hybrid event with a public viewing followed by an online art auction and raffle. The public art viewing will be 5 to 8 p.m. Friday and Saturday at Alta’s newest location, the Mahoning Valley Campus of Care, 1960 E. County Line Road, Building 6 (the former Youngstown Developmental Center), Youngstown. Visitors are asked to wear a mask and have their temperatures taken at the door.
The virtual auction for the art and sale of tickets for the baskets will begin at 5 p.m. Friday and close 9 p.m. March 7. Links to the online auction will be made available online and across all social media closer to the auction.
Alzheimer’s event examines health disparities and Alzheimer’s Disease
Dr. Carl V. Hill
DAYTON COVID-19 has laid bare some undesirable truths: African Americans and Latinos are disproportionately impacted by the pandemic. In the field of Alzheimer’s and dementia, statistics point to a similar troubling trend.
On March 3, the Alzheimer’s Association will hosting a virtual statewide town hall assembling some of the nation’s top experts in the field of health equity and Alzheimer’s disease to discuss some of the latest research involving underserved communities. Dr. Carl V. Hill, Chief Diversity, Equity and Inclusion Officer for the Alzheimer’s Association, and Peter Lichtenberg, Ph.D., ABPP, President of the Gerontological Society of America (GSA), will host the event.
Examining health disparities and Alzheimer’s disease
Submitted story
Hill
DAYTON – On March 3, the Alzehimer’s Association is hosting a virtual statewide town hall, assembling experts in the fields of health equity and Alzheimer’s disease to discuss research involving underserved communities.
Dr. Carl V. Hill, Chief Diversity, Equity and Inclusion Officer for the Alzheimer’s Association, and Peter Lichtenberg, Ph.D., ABPP, President of the Gerontological Society of America, will host the event.
The Dr. James S. Jackson Seminar on Health Equity and Alzheimer’s Disease, which will be 5-6:30 p.m., will have speakers from The Ohio State University; the West Virginia University Rockefeller Neuroscience Institute; the University of Michigan; Michigan State University; and the Michigan Alzheimer’s Disease Research Center.
Immersive VR can enhance the pain-relieving effectiveness of spinal cord stimulation
For patients receiving spinal cord stimulation (SCS) for chronic pain, integration with an immersive virtual reality (VR) system - allowing patients to see as well as feel the effects of electrical stimulation on a virtual image of their own body - can enhance the pain-relieving effectiveness of SCS, reports a study in
PAIN
®, the official publication of the International Association for the Study of Pain (IASP). The journal is published in the Lippincott portfolio by Wolters Kluwer.
The integrated SCS-VR approach improves pain control over SCS alone, with fast-acting and long-lasting effects that may increase with repeated use, according to the new collaborative research by Olaf Blanke, MD, of Ecole polytechnique fédérale de Lausanne (EPFL), Geneva, Switzerland, Ali Rezai, MD, of West Virginia University Rockefeller Neuroscience Institute, and Vibhor Krishna MD, PhD, of the Ohio State Univer
Virtual Reality Gives Spinal Cord Stimulation a Boost
For patients receiving spinal cord stimulation (SCS) for chronic pain, integration with an immersive virtual reality (VR) system – allowing patients to see as well as feel the effects of electrical stimulation on a virtual image of their own body – can enhance the pain-relieving effectiveness of SCS, reports a study in
PAIN, the official publication of the International Association for the Study of Pain (IASP), published in the Lippincott portfolio by Wolters Kluwer.
The integrated SCS-VR approach improves pain control over SCS alone, with fast-acting and long-lasting effects that may increase with repeated use, according to the new collaborative research by Olaf Blanke, MD, of Ecole polytechnique fédérale de Lausanne (EPFL), Geneva, Switzerland, Ali Rezai, MD, of West Virginia University Rockefeller Neuroscience Institute, and Vibhor Krishna MD, PhD, of the Ohio State University and their colleagues.